Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Contego Medical Inc. announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual VIVA (Vascular InterVentional Advances), VIVA 23, being held Oct. 30-Nov. 2 in Las Vegas, NV. The PERFORMANCE II is a prospective, multicenter study evaluating the safety and effectiveness of the Neuroguard IEP System in 305 patients at 40 clinical sites.
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Global Embolic Protection Devices Market Size to Reach USD 1,242 9 Million in 2032 | Emergen Research sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.